Back to Search
CHRISTOPHER PEASE, MD
MD
Internal Medicine Physician
NPI: 1902105737IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
A127893(CA)T2014-095(AR)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
OTHER
Class of 2010
Research & Publications (20)
Diagnosing late onset rheumatoid arthritis, polymyalgia rheumatica, and temporal arteritis in patients presenting with polymyalgic symptoms. A prospective longterm evaluation.
PMID 15940765·J Rheumatol·2005
8-other
Measurement of CD4+ and CD8+ T-lymphocyte cytokine secretion and gene expression changes in p-phenylenediamine allergic patients and tolerant individuals.
PMID 19657353·J Invest Dermatol·2010
8-other
Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study.
PMID 18980958·Rheumatology (Oxford)·2009
4-observational
Activation of T-cells from allergic patients and volunteers by p-phenylenediamine and Bandrowski's base.
PMID 17914451·J Invest Dermatol·2008
4-observational
Mass spectrometric identification of covalent adducts of the skin allergen 2,4-dinitro-1-chlorobenzene and model skin proteins.
PMID 18440195·Toxicol In Vitro·2008
8-other
Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study.
PMID 18276741·Ann Rheum Dis·2008
2-rct
Assuring consumer safety without animal testing: a feasibility case study for skin sensitisation.
PMID 19025323·Altern Lab Anim·2008
7-preclinical
Development of a modified in vitro skin absorption method to study the epidermal/dermal disposition of a contact allergen in human skin.
PMID 19037761·Cutan Ocul Toxicol·2008
8-other
Chemical reactivity indices and mechanism-based read-across for non-animal based assessment of skin sensitisation potential.
PMID 17703503·J Appl Toxicol·2008
6-review
Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica.
PMID 17530680·Arthritis Rheum·2007
3-trial
The role of non-covalent protein binding in skin sensitisation potency of chemicals.
PMID 17612982·Cutan Ocul Toxicol·2007
8-other
Evidence for a different anatomic basis for joint disease localization in polymyalgia rheumatica in comparison with rheumatoid arthritis.
PMID 17907197·Arthritis Rheum·2007
4-observational
Physiologically-based Kinetic Modelling (PBK Modelling): meeting the 3Rs agenda. The report and recommendations of ECVAM Workshop 63.
PMID 18186671·Altern Lab Anim·2007
7-preclinical
Intermittent exposure to low-concentration paraphenylenediamine can be equivalent to single, higher-dose exposure.
PMID 17441847·Contact Dermatitis·2007
7-preclinical
Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles.
PMID 17177719·Contact Dermatitis·2007
8-other
Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein.
PMID 17317089·Toxicol In Vitro·2007
8-other
Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59.
PMID 17411362·Altern Lab Anim·2007
7-preclinical
Activation of human dendritic cells by p-phenylenediamine.
PMID 17108233·J Pharmacol Exp Ther·2007
8-other
Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review.
PMID 18220556·Curr Drug Metab·2007
6-review
Detection of density dependence requires density manipulations and calculation of lambda.
PMID 16602295·Ecology·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 MEDICAL PLAZA
ROSEVILLE, CA 95661 - Phone
- (916) 781-1927
Quick Facts
- NPI
- 1902105737
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 16
- Publications
- 20
Are you this provider?
Claim Your Profile